Ozempic, Mounjaro Lawsuit Survives Dismissal Motion in La. Federal Court



DOCUMENTS
  • Order
  • Order


LAKE CHARLES, La. — A Louisiana federal judge has refused to dismiss a lawsuit accusing Novo Nordisk A/S and Eli Lilly & Co. of failing to warn that their type 2 diabetes drugs Ozempic and Mounjaro can cause severe gastrointestinal issues, ruling the plaintiff adequately alleged her claims for inadequate warning.

In orders issued on Dec. 8 and 11, Judge James D. Cain Jr. of the U.S. District Court for the Western District of Louisiana also dismissed the breach of express warranty claim with leave to amend, and deferred ruling on the claims for punitive damages and attorneys’ fees.

Ozempic …

FIRM NAMES
  • Adams & Reese
  • DLA Piper US
  • Kirkland & Ellis LLP
  • Morgan & Morgan
  • Plauche Smith & Nieset LLC





UPCOMING CONFERENCES




HarrisMartin's Ozempic MDL Conference: Updates from the Status Hearing

March 15, 2024 - Philadelphia, PA
Kimpton Hotel Monaco Philadelphia

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

March 01, 2024 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS